Björn Rissiek
@brissiek.bsky.social
600 followers 1.5K following 24 posts
Immunologist at the Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf in Hamburg, Germany. Does Nanobody Discovery, interested in neuroinflammation and purinergic signalling. My opinion are my own.
Posts Media Videos Starter Packs
brissiek.bsky.social
Hey #IUIS2025 participants, check out our poster on Wednesday, August 20, 12:15 - 13:45 | Poster Area (Hall X5) #neuroimmunology. We brought data from our new "BrEndO" mouse model for cerebral vasculitis #CD8 #Tcells #immunology
Reposted by Björn Rissiek
siegenthalerlab.bsky.social
Pretty certain running a lab is mostly about making signs to avoid inconveniences & minor catastrophes. 😊
collage of pictures of
brissiek.bsky.social
Today, our blood sample preparation container arrived. Still needs to be filled with equipment 😊 then we are ready for the first blood samples in October #nanobodies #vhh #antibodies #immunology
brissiek.bsky.social
Boost #1 of Campaign #1: done 🦙😊
Reposted by Björn Rissiek
pjsaez.bsky.social
#HotFromThePress !!

What if instead of analyzing 4-6 pathology markers you could check >100 in the *same* sample?

@maltekuehl.com & co @puellesv.bsky.social lab introduce #PathoPlex, method that could even predict disease

Full www.nature.com/articles/s41...
@focalplane.bsky.social @nature.com 🧪🔬
Reposted by Björn Rissiek
statfourwork.bsky.social
It’s hard being a scientist these days and I’ve captured that indescribable feeling that we are all facing in a new word!!

open.substack.com/pub/profkap/...
Wissenschaftweltschmerz!
If you're a scientist, it's what you're feeling.
open.substack.com
brissiek.bsky.social
Today, we startet our first #nanobody discovery campaign by immunizing two of our alpacas, one by s.c. protein injection and one by gene gun. Crossing our fingers for a good HcAb response 🤞🏻💪🏻
brissiek.bsky.social
A warm welcome to our newest #nanobody discovery team member! “Occi” arrived this weekend and smothly joined the herd. Soon, she will help us generating new #nanobodies against antigen targets used in research and/or for medical application
brissiek.bsky.social
Should I check this #alpaca for #nanobodies conferring resistance to electric shock? … or should I first check the electric fence energiser 😆 #vhh #antibody
brissiek.bsky.social
Our alpaca mares have their summer coat since yesterday. Ethics are approved, antigen production is ongoing, and we hope to start the first round of immunization in July. Super excited!!! 🦙🧬🔬👨‍🔬
Reposted by Björn Rissiek
Reposted by Björn Rissiek
who.int
WHO @who.int · Apr 27
Vaccines have saved 154 million lives in the past 50 years. A reminder of what is #HumanlyPossible. Science saves lives.
#VaccinesWork

bit.ly/wiw2025
Every 10 seconds vaccination saves a life. Immunization for all is humanly possible.
brissiek.bsky.social
And here is the editor @pchoern.bsky.social Welcome to bluesky
brissiek.bsky.social
It is always a pleasure to get young students enthusiastic about science! A few days ago we had a whole class in our department, showcasing #Nanobody research. What can I say - it was fun! Hope to see some of you around on campus some time! #sfb1328
Reposted by Björn Rissiek
stephenturner.us
Not good.

75% of US scientists who answered Nature poll consider leaving www.nature.com/articles/d41...
Reposted by Björn Rissiek
jamiedaw.bsky.social
I received one of the 232 NIH grant "terminations" sent to scientists at Columbia last night. My research focuses on improving maternal and child health in the US. Also affected: ongoing clinical trials, research training programs, and research centers that aim to improve the health of Americans.
Hundreds of research grants at Columbia canceled following Trump edict, administrator says
The National Institutes of Health is terminating 232 grants for scientific research at Columbia University Irving Medical Center, according to an email an administrator sent to faculty.
gothamist.com
Reposted by Björn Rissiek
luckytran.com
Texas measles outbreak update: 124 cases, 18 hospitalized, & now the first death of a child, who was not vaccinated.

Tragic, preventable, & a direct consequence of the deadly lies spread by anti-vaxx grifters, one of whom is now the most powerful health official in the US.
Texas announces first death in measles outbreak
The Texas Department of State Health Services is reporting the first death from measles in the ongoing outbreak in the South Plains and Panhandle regions.
The school-aged child who was not vaccinated was hospitalized in Lubbock last week and tested positive for measles.
As of Feb. 25, 124 cases of measles have been confirmed in the outbreak since late January. Most of the cases are in children. Eighteen people have been hospitalized over the course of the outbreak.
brissiek.bsky.social
Exciting special issue coming up in 2025: #purinergic signaling is a fascinating cellular communication hub in many different organ and tissue systems…including the immune system. The special issue is curated and edited by colleagues from #SFB1328.

pubs.acs.org/doi/10.1021/...
Call for Papers – Purinergic Signaling: Medicinal Chemistry, Biology, Pharmacology, and Translation into Diagnostic and Therapeutic Drugs
OR SEARCH CITATIONS
pubs.acs.org
Reposted by Björn Rissiek
torreslab.bsky.social
Come and join our team at St. Jude Children's Research Hospital! We are seeking a Sr Scientist to advance our research on immune responses to infection/vaccination. This is a financially stable position offering a highly competitive salary and excellent benefits.
talent.stjude.org/careers/jobs...
Senior Scientist-Immunology, Vaccinology, Infection in Memphis, Tennessee | St. Jude Careers
St. Jude Careers is hiring a Senior Scientist-Immunology, Vaccinology, Infection in Memphis, Tennessee. Review all of the job details and apply today!
talent.stjude.org
Reposted by Björn Rissiek
dricks.bsky.social
New approach: Nanobody inhibitors that target Ebolavirus are under development at Univ of Minnesota. Nanobodies are tiny antibodies from animals like alpacas allowing access to viral regions too small for larger antibodies. This one blocks EBV's ability to enter human cells phys.org/news/2025-01...
Scientists develop nanobody inhibitors to target deadly Ebola virus
Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and safety. To address this challenge, researchers at the University of Minnesot...
phys.org
Reposted by Björn Rissiek
labliston.bsky.social
Our paper on nurturing a #PositiveResearchCulture within your #research #team published by @wellcometrust.bsky.social gives useful tips for your lab. As well as making you a good team leader, nurturing culture pays off in building your science: 1/11

wellcomeopenresearch.org/articles/9-3...
wellcomeopenresearch.org